Barclays’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $226K | Sell |
|
|||||
|
2025
Q2 | $188K | Buy |
|
|||||
|
2025
Q1 | $62K | Sell |
|
|||||
|
2024
Q4 | $65K | Hold |
|
|||||
|
2024
Q3 | $35K | Sell |
|
|||||
|
2024
Q2 | $41K | Sell |
|
|||||
|
2024
Q1 | $105K | Sell |
|
|||||
|
2023
Q4 | $224K | Buy |
|
|||||
|
2023
Q3 | $77K | Buy |
|
|||||
|
2023
Q2 | $26K | Buy |
|
|||||
|
2023
Q1 | $4K | Hold |
|
|||||
|
2022
Q4 | $3K | Hold |
|
|||||
|
2022
Q3 | $2K | Hold |
|
|||||
|
2022
Q2 | $2K | Hold |
|
|||||
|
2022
Q1 | $2K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $4K | Buy |
|
|||||
|
2019
Q2 | $9K | Hold |
|
|||||
|
2019
Q1 | $9K | Hold |
|
|||||
|
2018
Q4 | $6K | Hold |
|
|||||
|
2018
Q3 | $15K | Hold |
|
|||||
|
2018
Q2 | $9K | Hold |
|
|||||
|
2018
Q1 | $11K | Hold |
|
|||||
|
2017
Q4 | $13K | Hold |
|
|||||
|
2017
Q3 | $12K | Hold |
|
|||||
|
2017
Q2 | $17K | Hold |
|
|||||
|
2017
Q1 | $27K | Hold |
|
|||||
|
2016
Q4 | $9K | Sell |
|
|||||
|
2016
Q3 | $290K | Sell |
|
|||||
|
2016
Q2 | $403K | Sell |
|
|||||
|
2016
Q1 | $0 | Sell |
|
|||||
|
2015
Q4 | $713K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $0 | Hold |
|
|||||
|
2014
Q3 | $0 | Hold |
|
|||||
|
2014
Q2 | $0 | Hold |
|
|||||
|
2014
Q1 | $0 | Hold |
|
|||||
|
2013
Q4 | $0 | Hold |
|
|||||
|
2013
Q3 | $0 | Sell |
|
|||||
|
2013
Q2 | $1K | Buy |
|